Last update 30 Nov 2024

Esflurbiprofen

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Esflurbiprofen (JAN), Flurbiprofen, (s)-, Mentha Oil
+ [9]
Target
Mechanism
COX inhibitors(Cyclooxygenases inhibitors)
Active Indication
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
JP (28 Sep 2015),
Regulation-
Login to view timeline

Structure

Molecular FormulaC15H13FO2
InChIKeySYTBZMRGLBWNTM-JTQLQIEISA-N
CAS Registry51543-39-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoarthritis
JP
28 Sep 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Athletic InjuriesPhase 2
DE
20 May 2021
ContusionsPhase 2
DE
20 May 2021
Soft Tissue InjuriesPhase 2
DE
20 May 2021
Sprains and StrainsPhase 2
DE
20 May 2021
Acute PainPhase 2
US
01 Jul 2016
Ankle InjuriesPhase 2
US
01 Jul 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
200
rnkrlrzlij(mrezgtiiro) = ocugpjiqrp nvktkszigx (niiveelatn, arekttinbe - nclpjjzioj)
-
28 Sep 2023
rnkrlrzlij(mrezgtiiro) = rltbxsqgdn nvktkszigx (niiveelatn, qsoniuvcyo - padlodgqgq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free